Swedish model for PSA testing has little effect on mortality

January 26, 2015, University of Gothenburg

The spontaneous PSA testing that has been applied in Sweden in recent decades has only had a marginal effect on mortality. An organized screening focused on those who have the most to gain would, however, reduce the risk of dying from prostate cancer by over 40 percent. This is shown by studies at the University of Gothenburg.

In Sweden, national programs for of both cervical cancer (Pap smear tests) and breast cancer (mammography) are applied. A corresponding program for the screening of prostate cancer does not exist.

Opportunistic screening

Many men instead have PSA tests on their own initiative, so-called opportunistic screening. However, there is no national recommendation on how such a test program should be formulated.

In several large studies, researchers at the Sahlgrenska Academy, University of Gothenburg, have tested organized PSA screening of 10,000 randomly chosen men in the Gothenburg region, and compared with the outcome in opportunistic screening.

Reduces risk of dying

The studies show that an organized test program both identifies more cancer cases in an early, curable phase and sharply reduces the risk of dying:

  • In the group of men that was offered organized PSA screening, the risk of dying from prostate cancer decreased by 42 percent. In the group that was exposed to opportunistic screening, only a marginally reduced mortality was seen.
  • Converted to a calculation example, one prostate cancer death per 13 men diagnosed with prostate cancer was prevented in organized screening compared with one prostate cancer death per 23 diagnosed men prevented in opportunistic screening.

Small effects

"The opportunistic PSA screening that we have used in Sweden for 20 years is simply not effective, and has only marginally reduced the risk of men dying from the disease," says Rebecka Arnsrud Godtman who is publishing the studies in her dissertation.

The opportunistic screening also leads to a larger proportion of men being unnecessarily diagnosed with . Besides the mental strain from being diagnosed with cancer, these men are at risk of living with the side-effects of a treatment for the rest of their lives, without actually getting any positive effects, according to Rebecka Arnsrud Godtman.

Active surveillance

The Gothenburg researchers' conclusion is that the PSA screening in Sweden should take place in an organized program where men are regularly invited for tests. Screening should start at a relatively young age, around 50, and take place with frequent checks. To minimize the risks of overdiagnosis, older men and men with other diseases should not undergo PSA screening.

The risk of overtreatment can be reduced through so-called , where diagnosed are under careful observation and only treated if the tumor shows signs of becoming more aggressive. According to the dissertation, a full 60 percent of the tumors found in organized PSA screening can be handled with active monitoring.

Explore further: Active surveillance can reduce suffering among men with prostate cancer

More information: Link to dissertation: gupea.ub.gu.se/handle/2077/36913

Related Stories

Active surveillance can reduce suffering among men with prostate cancer

November 2, 2012
With active surveillance many men with prostate cancer could dispense with radiation treatment and surgery, and thus avoid adverse effects such as incontinence and impotence. This is the outcome of a study of almost 1,000 ...

Organized screening for prostate cancer does more harm than good

September 30, 2013
Prostate cancer screening using the prostate-specific antigen (PSA) test is widely used in France despite a lack of evidence showing that it reduces cancer deaths. Now, researchers have shown that men experience more harm ...

Prostate cancer mortality benefit seen for family Hx-based screens

January 19, 2015
(HealthDay)—Screening white men with a family history of prostate cancer appears to be associated with a decrease in prostate cancer-specific mortality, according to a study published in the January issue of The Journal ...

Four reasons I won't have a prostate cancer blood test

December 11, 2014
Cancer Council Australia and the Prostate Cancer Foundation of Australia yesterday released new draft guidelines to help GPs counsel men who ask about prostate cancer tests. They advise GPs to explain the pros and cons of ...

Alternative PSA screening strategies could reduce harm

February 5, 2013
(HealthDay)—Compared with standard screening, alternative prostate-specific antigen (PSA) screening strategies could maintain good prostate cancer detection rates while reducing overdiagnoses and unnecessary biopsies, according ...

PSA-testing and early treatment decreases risk of prostate cancer death

March 10, 2014
Mortality in prostate cancer is lower in areas with frequent use of PSA testing compared with areas with little testing shows a study published online today in Journal of the National Cancer Institute by researchers from ...

Recommended for you

Boosting cancer therapy with cross-dressed immune cells

January 22, 2018
Researchers at EPFL have created artificial molecules that can help the immune system to recognize and attack cancer tumors. The study is published in Nature Methods.

Workouts may boost life span after breast cancer

January 22, 2018
(HealthDay)—Longer survival after breast cancer may be as simple as staying fit, new research shows.

Cancer patients who tell their life story find more peace, less depression

January 22, 2018
Fifteen years ago, University of Wisconsin–Madison researcher Meg Wise began interviewing cancer patients nearing the end of life about how they were living with their diagnosis. She was surprised to find that many asked ...

Single blood test screens for eight cancer types

January 18, 2018
Johns Hopkins Kimmel Cancer Center researchers developed a single blood test that screens for eight common cancer types and helps identify the location of the cancer.

Researchers find a way to 'starve' cancer

January 18, 2018
Researchers at Vanderbilt University Medical Center (VUMC) have demonstrated for the first time that it is possible to starve a tumor and stop its growth with a newly discovered small compound that blocks uptake of the vital ...

How cancer metastasis happens: Researchers reveal a key mechanism

January 18, 2018
Cancer metastasis, the migration of cells from a primary tumor to form distant tumors in the body, can be triggered by a chronic leakage of DNA within tumor cells, according to a team led by Weill Cornell Medicine and Memorial ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.